The Claim
In rat models of esophagitis and impaired lower esophageal and pyloric sphincter function, BPC 157 administration restores sphincter pressure to normal levels and reduces esophageal inflammation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rats with esophageal inflammation and weakened sphincters, BPC 157 restores normal sphincter pressure and decreases inflammation in the esophagus.
See the scientific wording
In rat models of esophagitis and impaired lower esophageal and pyloric sphincter function, administration of BPC 157 restored sphincter pressure to normal levels and reduced esophageal inflammation, suggesting a potential role in modulating gastrointestinal motility and mucosal integrity under pathological conditions.
BPC 157 increases nitric oxide in the gut, which opens blood vessels and grows new ones to repair damaged tissue. It also stops harmful chemicals from damaging cells. Together, this fixes the lining of the esophagus and makes the valves at the top and bottom of the stomach work properly again.
What the research says
1 studyStudy: Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.
In rats with a sore esophagus and leaky valves, a special peptide called BPC 157 fixed the valves and reduced the soreness, showing it can help heal damaged digestive systems.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.